CBD Archives - Page 5 of 13 - InvestorWire (IW)

Monday Jun 06, 2022 - 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory AffairsBell will help further the company’s domestic and global expansion strategy and lead government relations in key international marketsShe will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programsBell also participated in the first event in her new position- the Florida Industrial Hemp…

Friday Jun 03, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better

Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodiesLexaria’s patented DehydraTECH technology has been studied in combination with a number of other products, including but not limited to, cannabidiol (“CBD”), oral nicotine, antivirals, NSAIDs, and erectile dysfunction therapiesThe company is pursuing…

Wednesday Jun 01, 2022 - 11:15 am

With a Focus on Accountability, Prime Harvest Inc. Continues to Grow as a Leader in California’s Cannabis Industry

Prime Harvest is a California-based tech-driven full-service cannabis corporation focused on direct-to-consumer operations, licensing acquisition, compliance management, and state-wide deliveryPrime Harvest fuses integrity into operations, dedicated to redefining the customer experience, being a force for good within the communities they serve, while building a valuable enterpriseMember of Community Alliance Program (“CAP”), supports education, arts initiatives, and military veteran organizations in local Southern CaliforniaCompany launched Jaxx…

Friday May 27, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technologyThe DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastesLexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applicationsThe company operates several subsidiary companies to focus on different commercial opportunities Ever since acquiring its…

Wednesday May 25, 2022 - 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Increases Vessel’s Footprint in the Canadian Cannabis Marketplace; Expands Its Operational Footprint in the E.U. and UK

Flora Growth’s Vessel brand just got listed on the Ontario Cannabis Store (“OCS”)Vessel also launched its direct-to-consumer online store to take control of its customer relationship journeyFlora, through this expansion, seeks to tap into the growing Canadian cannabis market, which is valued at an estimated CAD 5.9 billion in 2022The company has also expanded its operational footprint in Europe and the U.K. in a move…

Wednesday May 25, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Waves in the Growing Antiviral Drug Space with its DehydraTECH Technology

Lexaria Bioscience Corp., through its patented DehydraTECH technology, is improving the way many drugs enter the bloodstreamIn June 2021, the company proved that an antiviral drug enhanced with its technology was effective at inhibiting the COVID-19/SARS-CoV-2 virusWith the global antiviral market projected to hit $66.7 billion by 2025, Lexaria plans to capitalize on this growth by pushing its DehydraTECH technology and exploring multiple avenues of…

Monday May 23, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Year-end Report Shows Significant Revenue and Profit Growth, with Expectations for Further Rapid Growth in 2022

Cannabis cultivator and distributor Flora Growth has announced its annual financial and operating results, showing “significantly higher” revenues and profit gain for 2021 over the previous yearFlora maintains an outlook for 2022 of an additional 288 to 400 percent revenue growth by year end, largely driven by the company’s acquisition of consumer wellness brand JustCBDThe JustCBD acquisition increased Flora’s reach to more than half a…

Tuesday May 17, 2022 - 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Board of Directors following Tim Leslie’s Addition and Luis Merchan’s Appointment as Chairman

Luis Merchan, Flora Growth’s CEO, will serve as the new Chairman of the BoardTim Leslie, the Chairman of the company’s Advisory Board, will serve on its Board and audit committeeFlora Growth’s management is confident that these changes will position it as a U.S-based issuer while increasing its access to U.S-based investment Since the beginning of 2022, Flora Growth (NASDAQ: FLGC) has been making strategic moves…

Wednesday May 11, 2022 - 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Influencing the Pharmaceutical Industry

Lexaria began its human clinical study on oral nicotine alternatives, evaluating the effectiveness of its DehydraTECH-nicotine pouch performance Earlier in the year, the company also announced the commencement of its HYPER-H21-4 human clinical study on the effectiveness of DehydraTECH-processed CBD for hypertension treatmentLexaria has also made some significant progress in the use of its technology for the enhanced delivery of antiviral drugsIt hopes that before the…

Monday May 09, 2022 - 9:45 am

Advanced Container Technologies Inc. (ACTX) Offers New Tech with GrowPod Automated, Indoor Micro-Farms

Innovators in food supply field have been developing new technologies such as indoor farmsThese game-changing micro-farms can be built anywhereACTX is the exclusive distributor of GrowPods in the United States With global supply chain issues grabbing headlines and impacting almost every industry, potential solutions in any sector are certain to capture attention. Hence Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is…

Thursday May 05, 2022 - 12:14 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Readying Human Study to Compare Lexaria’s DehydraTECH-Nicotine Pouch Performance to that of Existing Leading Brands

In its most recent oral nicotine study, Lexaria established that DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls and peak levels achieved were up to 10x higher than controlsLexaria hopes to evidence in its upcoming human oral nicotine study NIC-H22-1, that processing purified nicotine with DehydraTECH leads to better oral-tissue absorption and reduced negative experiences compared to currently sold brandsLexaria’s DehydraTECH…

Thursday May 05, 2022 - 11:25 am

Advanced Container Technologies Inc. (ACTX) GrowPods ‘Ideally Suited’ for New USDA Food System Initiative

Up to $400 million has been made available to support food purchases with emphasis on purchasing from underserved farmers, ranchersAgency strengthens efforts to provide emergency food assistance, expand economic opportunityACTX GrowPods could be valuable tool in effort to build resilient local, regional food-production capabilities In an effort to provide transform the food system and build a better food system after the global pandemic exposed weaknesses…

Tuesday May 03, 2022 - 9:30 am

Prime Harvest Inc. Is ‘One to Watch’

Prime Harvest is leveraging a long-term strategy of investing in the growth and scale of licensed assets in California, anchored by the power of data-driven technologyIts flagship brand, Jaxx Cannabis, aims to use technology to facilitate a true customer-centric culture while enhancing the overall craft cannabis experienceThe company is committed to the goal of creating a more sustainable environment, now and in the futurePrime Harvest…

Tuesday May 03, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Update on its Patented DehydraTECH(TM) Technology, Including the Approval of New Patent

Lexaria received its 25th patent – and the first patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugsThe company is seeking IND approval from the FDA and has commenced its human HYPER-H21-4 study for hypertension with DehydraTECH-CBD, with results expected in Q3 2022Lexaria is also commencing its human oral nicotine study, NIC-H22-1 to compare Lexaria's DehydraTECH-nicotine pouch performance to that…

Monday May 02, 2022 - 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strengthens Financial Profile with Debt Reduction, Adjustments to Revenue Strategy

Red White & Bloom Brands is a multi-state cannabis operator based in Canada and focused on developing revenue opportunities in strong U.S. cannabis markets such as Michigan, Florida and CaliforniaThe company recently announced it has eliminated $115 million in debt liabilities as part of its efforts to streamline its financial operations during a period when many companies are struggling with the effects of the COVID…

Friday Apr 29, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in MichiganThe debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape productsRWB expects to release its full-year 2021 results on May 2, with the management hosting a conference call on May 3…

Friday Apr 29, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugsThis becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S.It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwideOver the 2022 calendar year, the company seeks to also pursue regulatory and commercial advancement In 2016, Lexaria Bioscience (NASDAQ: LEXX)…

Wednesday Apr 27, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Fourth Human Study for Reducing Hypertension, Reports Positive Outcome of Third Human Study’s Data

Global drug delivery innovator Lexaria Bioscience is researching the ability of its patented DehydraTECH(TM) technology to improve the performance of a number of prescription drugs Lexaria is a world leader in the investigation of a DehydraTECH-processed cannabidiol (“CBD”) to potentially treat high blood pressure (hypertension), and study outcomes thus far have rendered positive results on effectiveness and patient toleranceThe company is building a scorecard of data…

Monday Apr 25, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research to Support Safer, More Effective Oral Alternative to Harmful Pulmonary Administration Practices

Lexaria expects to begin dosing this summer as part of a human nicotine study, NIC-H22-1, to compare DehydraTECH-nicotine pouch performance to that of existing leading brands such as ON! and ZynSo far, the company’s animal studies have evidenced that the technology delivers outstanding results, including faster delivery, an increase in the quantity of peak nicotine delivered, higher brain levels of nicotine, and enhanced bioavailabilityIn its…

Friday Apr 22, 2022 - 9:00 am

Hero Technologies Inc. (HENC) Looks to Expand as States Report $3.7B in Cannabis Recreational Tax Revenue in 2021

MPP report notes that states with legalized marijuana for adult use generated $3.7 billion in tax revenue from recreational cannabis salesHENC is looking to leverage its cannabis expertise in more of these statesCompany is aggressively pursuing expansion into Colorado, Massachusetts A new report reveals that states with legalized recreational marijuana collected an estimated $3.7 billion in tax revenues last year (https://ibn.fm/iBUXq). That news bodes well…

Wednesday Apr 20, 2022 - 9:30 am

Hero Technologies Inc. (HENC) Eyes Passage of Marijuana Act as Plans Include Expansion into Colorado, Massachusetts

U.S. House passes key cannabis bill to remove cannabis from federally banned substancesA 2021 Pew Research Center poll indicates 91% of Americans agree that either medical or recreational cannabis use should be allowedHENC plans to expand into two states — Colorado and Massachusetts — that have legalized cannabis For the second time, the U.S. House of Representatives has passed a bill designed to end the…

Wednesday Apr 20, 2022 - 9:15 am

Flora Growth Corp. (NASDAQ: FLGC) Celebrates Finalization of Colombian Cannabis Export Protocols

Global cannabis brand Flora Growth Corp. is enjoying new opportunities for supplying its Colombian-grown high-THC and high-CBD flower to international markets, thanks to the finalization of regulatory framework allowing legal cannabis exports from the South American countryFlora Growth is authorized to export non-psychoactive cannabidiol (“CBD”) products as well as up to 43,600 kg of products with high-tetrahydrocannabinol (“THC”) psychoactive cannabis contentFlora Growth’s Cosechemos cultivation facility…

Monday Apr 18, 2022 - 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advances its Human Nicotine Study and Announces New Nicotine Formulation Creation and Evaluation Program with Altria

Lexaria’s patented DehydraTECH(TM) technology has proven, in the NIC-A21-1 animal study, to be 10-20 times faster in reaching peak delivery of nicotine to the bloodstream than controlsThe company hopes to affirm this in the NIC-H22-1 human nicotine study as their DehydraTECH-nicotine pouch performance will be compared to existing leading brands currently sold in the United States such as ON! and ZynLexaria has separately announced new…

Tuesday Apr 12, 2022 - 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Gaining Advantage on Processing Rare Cannabinoids with the Help of Subsidiary Bay Medica

There is an urgent need for large-scale biosynthetic processing that preserves the purity and consistency of cannabinoidsAcquired by InMed in October 2021, Bay Medica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sectorInMed has two cannabinol formulations currently in development for ocular and dermatological diseases – INM-088 (ocular for glaucoma) and INM-755 (dermatological cream…

Tuesday Apr 12, 2022 - 9:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments

Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technologyThe company has conducted both in vitro testing and in vivo animal and human testing to evaluate the ability of DehydraTECH to improve the delivery of various APIs (active pharmaceutical ingredients)Lexaria has multiple other studies lined up aimed at building sufficient data to effect meaningful industry and/or…

Wednesday Apr 06, 2022 - 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potentialInMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT productsThe company recently reported its first revenues from…

Wednesday Apr 06, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”)The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIsLexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, and moreAccording to company CEO Chris Bunka, the management team is positioning…

Monday Apr 04, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Building a House of Brands, Is Creating World-Class Standards for Environmental Impact, Social Justice, and Corporate Governance, to Navigate Increasing Commoditization in its Market Segment

Red White & Bloom, a multi-state operator in cannabis and hemp-derived product lines, has built a platform to strengthen its brands, enabling it to wade through the difficulties of increasing product commoditizationThe company expects to showcase the results of the buildout process in the coming monthsRWB is also committed to fostering public and local input, equitable leadership opportunities, and removing systemic structures that marginalize segments…

Friday Apr 01, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and moleculesLexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol (“CBD”) in treating high blood pressure and epileptic conditionsThe company continues its research demonstrating the ability of its technology -to enhance the performance of antiviral drugs…

Thursday Mar 31, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan

RWB’s mission has always been to become the superior and most recognizable cannabis company in the United StatesIt seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitionsSo far, in 2022, the company has announced the acquisition of PharmaCo, which sees the transfer of 21 medical and adult-use cannabis licensesRWB has also closed…

Thursday Mar 31, 2022 - 9:00 am

Hero Technologies Inc. (HENC) Subsidiary Establishes Presence in Booming Colorado Cannabis Market

Cannabis sales in Colorado broke another record last year, topping $2.22 billion in products soldCannabis is “massive” driver of tax revenue for Colorado, raking in over $423 million last year aloneHENC continues to pursue diversification and integration strategy through subsidiary Another record-breaking year for Colorado’s cannabis industry bodes well for Hero Technologies (OTC: HENC). The company anticipates expanding into the booming market via cultivation and dispensary operations through…

Tuesday Mar 29, 2022 - 9:00 am

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

HENC is focusing on expansion of current operations, future growth in industryCompany aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”)Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC) strategic business plan and operations. As a featured guest during a recent episode of the Bell2Bell…

Friday Mar 25, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia

Cannabis product cultivator Flora Growth Corp. operates a premium growing facility in central Colombia and has received a growing list of authorizations to export its cannabis products for varied health and wellness purposesFlora Growth’s authorized distribution of low-THC CBD cannabis derivatives has been recently expanded to include a quota of up to 43,600 kg of products with high-THC cannabisFlora also reached agreement with Israel-based DNO…

Tuesday Mar 22, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavorsThe epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulationThe global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to reach $111.8 billion by 2030, driven by an increase in demand for…

Monday Mar 21, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDAIts acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar yearWith these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader In 2021, Flora Growth…

Friday Mar 18, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Imports First CBD Products from Colombia Operations to U.S., with National Distribution Boost from Recent JustCBD Acquisition

Flora Growth is a cannabis cultivator and distributor operating a 100-hectare (about 247-acre) harvesting site called Cosechemos in central Colombia’s favorable growing climateFlora Growth has completed its first import of CBD-containing food and beverage products into the United States under its Mambe brand, thanks to Colombian regulatory changes in recent months allowing cannabis product exportsFlora has filed licenses for 23 cannabinoid-infused food and beverage products…

Monday Mar 14, 2022 - 9:30 am

Hero Technologies Inc. (HENC) Applies for Listing on OTCQB, Committed to Inform and Engage Investors

CEO affirms “it is essential that our shareholders and other investors understand that we are committed to sharing information transparently”OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving fair valuationHENC also hopes to engage several entities, individuals and influencers to post on social media sites In a strategic move designed to inform and engage investors, Hero Technologies (OTC: HENC) has applied…

Thursday Mar 10, 2022 - 11:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Quality, Consistency in Florida, Michigan Operations

Red White & Bloom Brands is a cannabis and hemp multi-state operator, focused on product consistency and quality, critical to the developing cannabis market that is rapidly growing state by stateThe company’s successes in Michigan, a leading U.S. cannabis market, include the acquisition of full licensing, a 15,000-square-foot manufacturing and distribution facility, and more than 20 new potential locations for cultivation and dispensariesIn Florida, RWB…

Wednesday Mar 09, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strengthens Foothold in U.S. Wellness Market with Acquisition of JustCBD, Appoints Jessie Casner as CMO

Flora Growth owns and operates a portfolio of brands offering wholesale products, consumer packaged goods, or pharmaceutical and medical productsThe three-pronged operational approach has allowed the company to substantially expand and accelerate its revenue growth over the short termRecently, Flora Growth added yet another brand, JustCBD, to its portfolio; JustCBD’s performance is expected to immediately contribute to FLGC’s 2022 revenues and earningsFlora Growth also appointed…

Tuesday Mar 08, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Is ‘One to Watch’

ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops year-roundACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow PodsATCX is established in the rapidly growing cannabis packaging industryThe company is well positioned in multiple recession-resistant markets Advanced…

Articles

Articles Category: CBD

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions